Lite Paper: Real-World PD-L1 Testing Data Provides Insight into the Evolving Immuno-oncology Landscape
Blog
Read More
A single-tube NGS assay for simultaneous detection of DNA and RNA biomarkers as a comprehensive solution for clinical management and guiding therapeutic intervention of Ph-like ALL patients
Literature
Read More
Case Study: How Pharma Uses NeoGenomics Real-World Oncology Data to Accelerate Biomarker Adoption and Commercial Launch
Blog
Read More
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch
Press Release
Read More
NeoGenomics announces speaker program, ‘Minimal Residual Disease in Colorectal Cancer’
Blog
Read More